Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04357288 · ClinicalTrials.gov registry record · NA
Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 1,117
- Enrollment target
NCT04357288: Completed NA study, sponsored by University of Utah.
NCT04357288 is a NA study that has completed, run by University of Utah. The registered enrollment target is 1,117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (20% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04357288, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,117 participants
- Enrollment target
Study Summary
This study will compare the effectiveness of the use of a Patient Decision Aid (PDA) and an Encounter Decision Aid (EDA) on Shared Decision Making (SDM) and health outcomes for at-risk participants with Atrial Fibrillation (AF) at 6 study sites. We hypothesize the combination of the PDA and EDA will be more effective in promoting high-quality SDM and in adoption of and adherence to anticoagulation than either tool alone.
Primary Outcome
Validated scale of 16 questions that evaluates 1) uncertainty in making a healthcare decision, 2) factors contributing to the uncertainty, and 3) the participant's perceived effective decision making. Answers range in a 5 point Likert scale from 0=strongly agree to 4=strongly disagree. Clarity and understanding are indicated if the participant "strongly agrees" to the statements, so smaller scores are better.
Interventions
- OTHER Patient Decision Aid
- OTHER Encounter Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,117 participants |
| Start Date | 2020-12-16 |
| Est. Completion | 2024-09-20 |
| Phase | NA |
What the finished NCT04357288 record still lists
NCT04357288 is an interventional study that assigns participants to a tested intervention. Its 1,117 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (20% lower).
The record links to 0 conditions, and to 2 interventions - of which Patient Decision Aid is the first listed.
NCT04357288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04357288 about?
NCT04357288 is a clinical study titled "Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation". This study will compare the effectiveness of the use of a Patient Decision Aid (PDA) and an Encounter Decision Aid (EDA) on Shared Decision Making (SDM) and health outcomes for at-risk participants with Atrial Fibrillation (AF) at 6 study sites. We hypothesize the combination of the PDA and EDA will...
What is the current status of trial NCT04357288?
This trial is currently completed. It is a NA study. The enrollment target is 1,117 participants. The study started on 2020-12-16. Estimated completion is 2024-09-20.
What interventions are being tested in trial NCT04357288?
The interventions under investigation include: Patient Decision Aid (OTHER), Encounter Decision Aid (OTHER).
Who is sponsoring clinical trial NCT04357288?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04357288's enrollment target sits among peer trials
1,117 93rd of 2000 higher than 1,908 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI